Life Sciences Tools and Services
Company Overview of Cellca GmbH
Cellca GmbH develops protein-specific high expression cell lines and upstream processes for the medium and large-scale manufacture of biopharmaceuticals in mammalian cells. It transfers the process into customer's specific disposable bioreactor system; and recommends a disposable bioreactor with an optimized high-titre non-GMP process. The company also offers media powders and liquid ready-to-use media. It serves pharmaceutical and biotechnology companies. The company was founded in 2005 and is based in Laupheim, Germany. As of July 1, 2015, Cellca GmbH operates as a subsidiary of Sartorius Stedim Biotech S.A.
Founded in 2005
49 7392 96648 10
49 7392 96648 29
Key Executives for Cellca GmbH
Cellca GmbH Key Developments
Similar Private Companies By Industry
|Alacris Theranostics GmbH||Europe|
|Amcapharm Pharmaceutical GmbH||Europe|
|AMS Advanced Medical Services GmbH||Europe|
Recent Private Companies Transactions
|No transactions available in the past 12 months.|
The information and data displayed in this profile are created and managed by S&P Global Market Intelligence, a division of S&P Global. Bloomberg.com does not create or control the content. For inquiries, please contact S&P Global Market Intelligence directly by clicking here.
Most Searched Private Companies
|Company Name||Geographic Region|
|Lawyers Committee for Civil Rights Under Law||United States|
|NYC2012, Inc.||United States|
|Rush University||United States|
|The Advertising Council, Inc.||United States|
Sponsored Financial Commentaries
Only a company representative may request an update for the company profile. Documentation will be required.
To contact Cellca GmbH, please visit --. Company data is provided by S&P Global Market Intelligence. Please use this form to report any data issues.